Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

The intelligence a $25K terminal charges for — the day it breaks, in your market, at a fraction of the price.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Acquisition/DispositionItem 2.01 · 8-KLOW RiskPositive

Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks
Filed: Apr 3, 2026Boston, MassachusettsCIK: 0001830214Other
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Ginkgo Bioworks completed its acquisition of Tower Biosecurity (also known as Perimeter Systems) on April 3, 2026, to strengthen its biosecurity capabilities and expand market presence in the biosecurity domain.

Key Takeaways

Acquisition of Tower Biosecurity/Perimeter Systems completed on April 3, 2026 under a Stock Purchase Agreement dated February 26, 2026

Strategic move designed to enhance Ginkgo's biosecurity capabilities and align with growth objectives

2 more takeaways

Related Filings (1)

1 more filing from Ginkgo Bioworks Holdings, Inc. in the last 90 days

Filing Overview

Form Type8-K
Filing DateApr 3, 2026
Item2.01
CategoryAcquisition/Disposition
CIK0001830214
Accession #dna-20260403
Risk LevelLOW
SentimentPositive
Signalopportunity
Topics
acquisitionexpansion

What This Means

The company completed a major acquisition or sold off a significant asset. This reshapes the company's portfolio and strategic direction.
View Full Filing on SEC.govBrowse More Filings